Repository logo
 
Publication

A prime-boost immunization strategy with vaccinia virus expressing novel gp120 envelope glycoprotein from a CRF02_AG isolate elicits cross-clade Tier 2 HIV-1 neutralizing antibodies

2020-04-07Journal article Open access
Simple item page
dc.contributor.authorCalado, Rita
dc.contributor.authorDuarte, Joana
dc.contributor.authorBorrego, Pedro
dc.contributor.authorMarcelino, José Maria
dc.contributor.authorBartolo, Inês
dc.contributor.authorMartin, Francisco
dc.contributor.authorFigueiredo, Inês
dc.contributor.authorAlmeida, Silvia
dc.contributor.authorGraça, Luis
dc.contributor.authorCarrapiço, Belmira
dc.date.accessioned2022-04-20T22:14:19Z
dc.date.available2022-04-20T22:14:19Z
dc.date.issued2020-04-07
dc.descriptionResearch Areas: Immunology ; Research & Experimental Medicinept_PT
dc.description.abstractDevelopment of new immunogens eliciting broadly neutralizing antibodies (bNAbs) is a main priority for the HIV-1 vaccine field. Envelope glycoproteins from non-B-non-C HIV-1clades have not been fully explored as components of a vaccine. We produced Vaccinia viruses expressing a truncated version of gp120 (gp120t) from HIV-1 clades CRF02_AG, H, J, B, and C and examined their immunogenicity in mice and rabbits. Mice primed with the recombinant Vaccinia viruses and boosted with the homologous gp120t or C2V3C3 polypeptides developed antibodies that bind potently to homologous and heterologous envelope glycoproteins. Notably, a subset of mice immunized with the CRF02_AG-based envelope immunogens developed a cross-reactive neutralizing response against tier 2 HIV-1 Env-pseudoviruses and primary isolates. Rabbits vaccinated with the CRF02_AG-based envelope immunogens also generated potent binding antibodies, and one animal elicited antibodies that neutralized almost all (13 of 16, 81.3%) tier 2 HIV-1 isolates tested. Overall, the results suggest that the novel CRF02_AG-based envelope immunogens and prime-boost immunization strategy elicit the type of immune responses required for a preventive HIV-1 vaccine.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationCalado R, Duarte J, Borrego P, Marcelino JM, Bartolo I, Martin F, Figueiredo I, Almeida S, Graca L, ... Carrapiço B. 2020. A prime-boost immunization strategy with vaccinia virus expressing novel gp120 envelope glycoprotein from a CRF02_AG isolate elicits cross-clade Tier 2 HIV-1 neutralizing antibodies, Vaccines, 8(2):171. Doi: 10.3390/vaccines8020171pt_PT
dc.identifier.doi10.3390/vaccines8020171pt_PT
dc.identifier.eissn2076-393X
dc.identifier.urihttp://hdl.handle.net/10400.5/24131
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherMDPIpt_PT
dc.relationPGG/015/2016pt_PT
dc.relationPGG/02/2015pt_PT
dc.relationDEVELOPMENT AND PRE-CLINICAL EVALUATION OF A NEW HIV-1 VACCINE CONCEPT
dc.relationDESENVOLVIMENTO DE NOVOS MICROBICIDAS PARA PREVENIR A INFECÇÃO POR VIH
dc.relation.publisherversionhttps://www.mdpi.com/2076-393X/8/2/171pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectHIV-1 vaccinept_PT
dc.subjectRecombinant Vaccinia viruspt_PT
dc.subjectEnvelope glycoproteinspt_PT
dc.subjectNon-B-non-C cladespt_PT
dc.subjectBALB/c micept_PT
dc.subjectNew Zealand White rabbitspt_PT
dc.subjectBroadly neutralizing antibodiespt_PT
dc.titleA prime-boost immunization strategy with vaccinia virus expressing novel gp120 envelope glycoprotein from a CRF02_AG isolate elicits cross-clade Tier 2 HIV-1 neutralizing antibodiespt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleDEVELOPMENT AND PRE-CLINICAL EVALUATION OF A NEW HIV-1 VACCINE CONCEPT
oaire.awardTitleDESENVOLVIMENTO DE NOVOS MICROBICIDAS PARA PREVENIR A INFECÇÃO POR VIH
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F87488%2F2012/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F70715%2F2010/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT//SFRH%2FBPD%2F76225%2F2011/PT
oaire.citation.conferencePlaceBasel, Switzerlandpt_PT
oaire.citation.titleVaccinespt_PT
oaire.citation.volume8(2):171pt_PT
oaire.fundingStreamSFRH
person.familyNameCarrapiço
person.givenNameBelmira
person.identifier.orcid0000-0002-1936-5697
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication8507b4e1-c680-4a14-876a-ae78d22f7005
relation.isAuthorOfPublication.latestForDiscovery8507b4e1-c680-4a14-876a-ae78d22f7005
relation.isProjectOfPublication1da13129-1d97-4fb5-9f27-7d73cb47877b
relation.isProjectOfPublication620d35e7-a0c0-439d-a4cc-481cc103b68f
relation.isProjectOfPublicatione3b7c207-d129-4c0c-b2b0-ea8199cad9f8
relation.isProjectOfPublication.latestForDiscoverye3b7c207-d129-4c0c-b2b0-ea8199cad9f8

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

CIISA - Artigos em revistas internacionais